As shown in Figure 5a, high EYA1 mRNA levels were associated with good prognosis, whereas low EYA1 expression was associated with poor outcome in the Versteeg dataset consisting of a cohort of 88 neuroblastoma patients. Here, EYA1 is linked to neuroblastoma.